CMIST Trial and ESR Leadership Meeting

Plans for CMIST Trial Announced

The American College of Radiology (ACR) recently announced plans for a clinical trial to determine if contrast enhanced spectral mammography (CESM) screening provides more accurate cancer detection compared to the combination of digital breast tomosynthesis and whole breast ultrasound in women with dense breasts.  The Contrast Enhanced Mammography Imaging Screening (CMIST) Trial, planned to begin in spring 2020, will be managed by the ACR Center for Research and Innovation and will be supported by the ACR, Breast Cancer Research Foundation and GE Healthcare.


ESR Annual Leadership Meeting

DB-I was well represented at the ESR Annual Leadership meeting in Genoa, which was attended by Cheryl Cruwys, DB-I’s European Educational Coordinator, along with European Education Ambassadors Prof. Michael Fuchsjäger (Austria), Prof. Boris Brkljačić (Croatia) and Dr. Magnús A. Lúðvíksson (Iceland). Cheryl attended as part of the ESR Patient Advisory Group, committed to developing and supporting ESR patient-focused initiatives.